The Impact and Mechanism of Action of Peptostreptococcus anaerobius on Chemotherapy Resistance in Human Colorectal Cancer
Turkish Journal of Gastroenterology · 2024
DOI: 10.5152/tjg.2024.24221 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Gastroenterology, 2024. Verfasst von Guangcai Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical Unive…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Peptostreptococcus, Feces, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background/Aims: Peptostreptococcus anaerobius plays an important role in the development of colorectal cancer, and previous studies by our group have demonstrated that Peptostreptococcus anaerobius promotes resistance to 5-Fu chemotherapy in animal models of colorectal cancer. In this study, the effects of Peptostreptococcus anaerobius on chemotherapy resistance in colorectal cancer and its possible mechanism of action were investigated from the clinical point of view. Materials and Methods: Patients were selected according to exclusion and inclusion criteria and divided into sensitive and chemotherapy groups (n = 20/group). Fecal samples were collected from the patients. The bacterial 16S rRNA genes in the samples were sequenced and the abundance and varieties in the fecal bacteria were compared between the 2 groups. Immunohistochemistry and Western blotting were used to assess interleukin 23 levels in tumor tissues.
Results
Significantly elevated abundance of Peptostreptococcus was observed in fecal samples from chemoresistant colorectal cancer patients compared to those from chemosensitive individuals. Immunohistochemistry and Western blotting results showed that chemoresistant patients had higher levels of interleukin 23 relative to chemosensitive patients and the levels were positively associated with Peptostreptococcus.
Conclusion
Peptostreptococcus may mediate the development of chemoresistant colorectal cancer by promoting the upregulation of interleukin 23. Efforts to target Peptostreptococcus thus have the potential to alter the prognosis of colorectal cancer patients. Cite this article as: Li G, Li W, Dai H, He X, Shi L, Zhang X. The impact and mechanism of action of Peptostreptococcus anaerobius on chemotherapy resistance in human colorectal cancer. Turk J Gastroenterol. 2024;35(10):763-771.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang, China.
- Clinical Research Center, Affiliated Hospital of Shandong Second Medical University, Weifang, China.
- School of Rehabilitation Medicine, Shandong Second Medical University, Weifang, China.
Zitieren
APA
Li, G., Li, W., Dai, H., He, X., Shi, L., & Zhang, X. (2024). The Impact and Mechanism of Action of Peptostreptococcus anaerobius on Chemotherapy Resistance in Human Colorectal Cancer. Turkish Journal of Gastroenterology. https://doi.org/10.5152/tjg.2024.24221
Vancouver
Li G, Li W, Dai H, He X, Shi L, Zhang X. The Impact and Mechanism of Action of Peptostreptococcus anaerobius on Chemotherapy Resistance in Human Colorectal Cancer. Turkish Journal of Gastroenterology. 2024. doi:10.5152/tjg.2024.24221
BibTeX
@article{Li2024,
author = {Li, Guangcai and Li, Wenwen and Dai, Hongsheng and He, Xialian and Shi, Lihong and Zhang, Xiaoqian},
title = {The Impact and Mechanism of Action of Peptostreptococcus anaerobius on Chemotherapy Resistance in Human Colorectal Cancer},
journal = {Turkish Journal of Gastroenterology},
year = {2024},
doi = {10.5152/tjg.2024.24221}
}
EUVIMED